Skip to main content
Home
  • Solutions
    Clinical solutions
    Blended Solutions Cardiac Safety Solutions Clinical & Scientific Operations Decentralised Clinical Trials Early Clinical Laboratories Medical Imaging Site & Patient Solutions Strategic Solutions
    Consulting & Commercial
    Asset Development Consulting Commercial Positioning Language Services Outcome Measures Real World Intelligence Regulatory Affairs Symphony Health data
    meeting
    Case studies

    Reducing time to market, delivering on quality, providing deep therapeutic expertise and enhancing R&D ROI.

    Innovative research tools showcase
    Technologies

    Technology solutions from early phase through to post-marketing.

  • Sectors
    Sectors

    ICON provides its full range of clinical, consulting and commercial services across several industry sectors.

    Read more
    Biotech Government and Public Health Medical Device Pharmaceuticals
    Biotechnology services navigation panel
    Biotech

    Developing transformative therapies requires a flexible approach.

    Employee engagement program overview
    ICON and You

    Partners making a difference.

  • Therapeutics
    Therapeutics
    Cardiovascular Central Nervous System Endocrine & Metabolic Disorders Hepatology Infectious Diseases Internal Medicine & Immunology Oncology
    Cross-therapeutics
    Biosimilars Cell and Gene Therapies Medical Device Pediatrics Rare & Orphan Diseases Vaccines Women's Health
    Obesity 2025 insights image
    Obesity

    A focus on combination therapies requires appropriate obesity-specific trial designs, long-term follow-up studies and diverse patient recruitment.

    Biological research visual element
    Therapeutics insights

    ICON's therapeutic experts contribute regularly to industry publications and the creation of thought leadership content. Read more.

  • Insights
    Insights
    Digital Disruption Patient Centricity Regulatory Intelligence Therapeutics insights Transforming Trials Value Based Healthcare Blog Videos Webinar Channel
    banners
    From bottlenecks to breakthroughs

    Human-centred strategies for faster study starts

    More than monitoring whitepaper
    More than monitoring

    How modern monitoring paradigms impact CRA roles

    digital globe network with icons
    Meeting requirements for Joint Clinical Assessments

    A planning guide for health technology developers

  • News & Events
    News & Events

    ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.

    Read more
    Press releases In the News Mediakit Awards Events Webinars Social media
    webinar
    When patients lead: Breaking barriers in ultra-rare disease drug development

    3 March 2026. Register today.

    brain
    Boosting clinical trial success in Alzheimer’s, Parkinson’s and other neurodegenerative diseases

    Watch the webinar.

  • About ICON
    About ICON
    Company history ICON at a glance ICON in Asia Pacific ICON in Latin America Leadership Quality
    ICON for
    Patients Volunteers Investigators Jobs & Careers Investors Suppliers
    Responsible business practice indicators
    Sustainability, charity, inclusion and belonging

    ICON Cares is our commitment to making a positive impact on our people, environment and our community.

    Modern reception area at Dublin office
    ICON at a glance

    Delivering successful outcomes across the clinical development lifecycle.

  • Careers
  • Investors
  • Contact
  • 日本語
  • 简体中文
  1. Home
  2. Investigators
  3. Clinical Study Investigators

Clinical Study Investigators

Page tools
Share Share
Facebook

Share on Facebook

Facebook

Share on X

Facebook

Share on Linkedin

Bluesky

Share on Bluesky

Clinical investigators play a vital role in bringing new and potentially life-saving medicines to markets faster, which in turn enables millions of people all over the world to live longer, healthier and happier lives.

ICON has worked on studies for over 350 of the world’s leading pharmaceutical, biotechnology and medical device companies. The studies have spanned all phases of the drug development cycle and have been in every major therapeutic area.

Over the years we have successfully built a close network of some of the world’s leading investigators who are supported by ICON’s senior scientists and clinicians. As well as contributing to the development of new drugs, investigators have been able to increase the availability of new drugs to their patients. 

We are always keen to increase our investigator pool and to work with the finest, most qualified investigators to advance the field of medicine.

If you would like to be considered for future clinical trials run by ICON, click on the links in the Related Information toolbar to register your information. Your information will be used by ICON staff to identify potential sites for upcoming trials.

Please note that by registering you automatically give ICON your permission to store the entered data electronically and process it as necessary for selection and contact purposes regarding new clinical trials.

Register for Early Phase Trials

Register as an ICON Investigator

Register for Phase II - IIIb trials and or Biosimilar Trials

Register as an ICON Investigator
In this section
In this section
  • Company history
  • ICON at a glance
  • Patients
  • Volunteers
  • ICON in Asia Pacific
    • Japan
    • India
    • China
  • Investigators
    • Clinical Study Investigators
    • Early Phase
    • Investigator Site Resource Centre
      • Commercial invoices – UK clinical trial sites shipping to ICON Dublin
      • FAQs
      • Holiday Schedule
      • Lab Certificates
      • Packaging instructions
      • Site training
      • Track Shipment
      • iSite
      • LabView360
    • Register
      • Early Phase
    • Transparency - Loi Bertrand Legislation
      • Contact
      • La Réglementation
      • Les données de transparence
  • ICON in Latin America
  • Jobs & Careers
  • Investors
  • Leadership
    • Board of Directors
  • Quality
  • Suppliers
  • Environmental, Social and Governance
    • Environment
    • Governance
    • Social

Connect with us

  • Contact us
  • Submit proposal request
  • Update Email Preferences
  • Global office locator
  • ICON on social media

Related information:

Webpage

FIRECREST - Site Performance Ignited

Factsheet

Biosimilars - QRG

Site Branding
    ICON plc
  • Contact
  • About ICON
  • Results & Reports
For Clients
  • Therapeutics
  • Solutions
  • Insights
  • Technologies
  • Content preferences
  • Office locations
ICON for
  • Patients
  • Volunteers
  • Investigators
  • Jobs & Careers
  • Investors
  • Suppliers
News & Events
  • Press releases
  • Mediakit
  • Events
  • Webinars
Socials
  • Linkedin
  • Facebook
  • Instagram
  • Youtube

Legal Footer

  • © 2026 ICON plc
  • Disclaimer
  • Privacy & Data
  • Cookies
How can we help?
  • All
  • Website
Popular search terms:
  • Biotech
  • Cell and Gene Therapies
  • Consulting
  • Early Clinical
  • Medical Device
  • Oncology
  • Rare & Orphan Diseases
  • Real World Evidence
  • Site & Patient Recruitment
  • Strategic Solutions
  • Regulatory Intelligence